Evidence map›Paper›PMID 39026667›Full record

ArticleFrontiers in immunology2024

Editorial: Immune tolerance and human malaria.

Katherine Rose Dobbs, Prasanna Jagannathan, Celia Dechavanne

Registry-linked trialAbstract readEditorial
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04978272 (Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04978272 phase3active not recruitingnot on this map

Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention

TypeinterventionalSponsorGrant Dorsey, M.D, Ph.D.Ran2022 to 2027Enrolled924ConditionsMalariaArmsDihydroartemisinin-piperaquine (DP), DP Placebo
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katherine Rose Dobbs *Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, United States.
Prasanna JagannathanDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, United States.
Celia Dechavanne *Université de Paris, Institut de Recherche pour le Développement (IRD), Mère et enfant en milieu tropical (MERIT), Paris, France.

Funding

Computational models of naturally acquired immunity to falciparum malariaU01AI150741 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUTTE, ATUL J, GREENHOUSE, BRYAN R · 2020 to 2024
$7.4M
Enhancing immunity to malaria in young children with effective chemopreventionU01AI155325 · NIAID · STANFORD UNIVERSITY · PI JAGANNATHAN, PRASANNA · 2021 to 2025
$6.3M
NIAID NIH HHS U01 AI150741NIAID NIH HHS U01 AI155325
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immune ToleranceMalariaAnimalsHumansdisease tolerancefetal immunityhuman malariaimmune tolerancemalaria in pregnancyprimed immunity

Identifiers

PMID39026667
PMCPMC11254803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.